Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12624000956505
Ethics application status
Approved
Date submitted
22/06/2024
Date registered
7/08/2024
Date last updated
7/08/2024
Date data sharing statement initially provided
7/08/2024
Type of registration
Prospectively registered
Titles & IDs
Public title
Does previous pregnancy loss increase the risk for gestational diabetes?
Query!
Scientific title
The effect of reproductive history on future risk of gestational diabetes.
Query!
Secondary ID [1]
312380
0
Nil Known
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Line by line individual data for 150 participants (participant's age, ethnicity, body mass index (BMI), presence of GDM, family history of diabetes, parity, number of previous miscarriages and pregnancy terminations, previous history of GDM) collected in year 2022 as part of the study: "To determine an association between metformin use in gestational diabetes mellitus and vitamin B12 deficiency" (trial id: ACTRN12620000397910) will also be included in this study" as part of existing database..
Query!
Health condition
Health condition(s) or problem(s) studied:
Gestational Diabetes
334173
0
Query!
Pregnancy loss
334174
0
Query!
Reproductive health and childbirth
334320
0
Query!
Condition category
Condition code
Metabolic and Endocrine
330840
330840
0
0
Query!
Diabetes
Query!
Reproductive Health and Childbirth
330977
330977
0
0
Query!
Antenatal care
Query!
Reproductive Health and Childbirth
330978
330978
0
0
Query!
Fetal medicine and complications of pregnancy
Query!
Intervention/exposure
Study type
Observational
Query!
Patient registry
False
Query!
Target follow-up duration
Query!
Target follow-up type
Query!
Description of intervention(s) / exposure
We will conduct a retrospective case control study, which will compare the previous exposures to pregnancy loss in women with and without diagnosis of gestational diabetes (GDM). This project will use the antenatal database from the Sutherland hospital for gestational diabetes data which were collected between years 2016 -2018. The antenatal database holds information on study participant's age, ethnicity, body mass index (BMI), presence of gestational diabetes, family history of diabetes, parity, number of previous miscarriages and pregnancy terminations, previous history of GDM, history of thyroid disease and thyroid hormone levels, gestational age and neonatal birth weight. We will be aiming to analyse data on 500 GDM women and these data will be matched with data on 500 women of similar age and BMI and ethnicity however without GDM.
Line by line individual participant data for 150 participants (participant's age, ethnicity, body mass index (BMI), presence of gestational diabetes, family history of diabetes, parity, number of previous miscarriages and pregnancy terminations, previous history of GDM) collected in year 2022 as part of the study: "To determine an association between metformin use in gestational diabetes mellitus and vitamin B12 deficiency" (trial id: ACTRN12620000397910) will also be included in this study".
Query!
Intervention code [1]
328878
0
Not applicable
Query!
Comparator / control treatment
It is a retrospective case control study, The control group will consist of 500 women without presence of GDM. who will be matched with examined GDM cases for age, BMI and ethnicity.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
338611
0
The study primary outcome is frequency of pregnancy loss in women with gestational diabetes as determined from medical records.
Query!
Assessment method [1]
338611
0
Query!
Timepoint [1]
338611
0
The study primary timepoint is the timing of delivery
Query!
Secondary outcome [1]
436607
0
Diagnosis of gestational diabetes in women with and without history of pregnancy loss, determined from medical records.
Query!
Assessment method [1]
436607
0
Query!
Timepoint [1]
436607
0
The timepoint of gestational diabetes diagnosis.
Query!
Eligibility
Key inclusion criteria
1) The exposure group consists of pregnant women with gestational diabetes who attended the antenatal Endocrine clinic at Sutherland Hospital during their pregnancy between 2016 and 2018.
2) The control group consists of pregnant women without a diagnosis of gestational diabetes, matched by age, BMI, and ethnicity, who also attended the antenatal Endocrine clinic at Sutherland Hospital during their pregnancy between 2016 and 2018.
3) Data for 150 participants collected in year 2022 as part of the study: "To determine an association between metformin use in gestational diabetes mellitus and vitamin B12 deficiency" (trial id: ACTRN12620000397910) will also be included in this study".
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
45
Years
Query!
Query!
Sex
Females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Women with Type 1 and 2 pre-gestational diabetes as well as women with BMI exceeding 35 kg/m2 will be excluded from the analysis, as their care was transferred to the tertiary referral centre.
Query!
Study design
Purpose
Natural history
Query!
Duration
Longitudinal
Query!
Selection
Case control
Query!
Timing
Retrospective
Query!
Statistical methods / analysis
Retrospective case control study which will compare the previous exposures to miscarriage/termination of pregnancies in women with and without diagnosis of GDM. We will be aiming to analyse data on 500 GDM women and these data will be matched with data on 500 women of similar age and BMI and ethnicity however without GDM. The proposed study design will have power of 0.80 and of 0.05 to detect a difference of 70% in GDM incidence in women with and without history of pregnancy loss
Query!
Recruitment
Recruitment status
Not yet recruiting
Query!
Date of first participant enrolment
Anticipated
1/09/2024
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
1/01/2025
Query!
Actual
Query!
Date of last data collection
Anticipated
1/03/2025
Query!
Actual
Query!
Sample size
Target
1000
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
NSW
Query!
Recruitment hospital [1]
26721
0
The Sutherland Hospital - Caringbah
Query!
Recruitment postcode(s) [1]
42760
0
2229 - Caringbah
Query!
Funding & Sponsors
Funding source category [1]
316788
0
Hospital
Query!
Name [1]
316788
0
Sutherland Hospital, NSW
Query!
Address [1]
316788
0
Query!
Country [1]
316788
0
Australia
Query!
Primary sponsor type
Hospital
Query!
Name
Sutherland Hospital
Query!
Address
Query!
Country
Australia
Query!
Secondary sponsor category [1]
319009
0
Individual
Query!
Name [1]
319009
0
Dr Dana Bliuc, UNSW, Sydney
Query!
Address [1]
319009
0
Query!
Country [1]
319009
0
Australia
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
315557
0
Aboriginal Health & Medical Research Council Ethics Committee
Query!
Ethics committee address [1]
315557
0
https://www.ahmrc.org.au/ethics-at-ahmrc/
Query!
Ethics committee country [1]
315557
0
Australia
Query!
Date submitted for ethics approval [1]
315557
0
15/08/2023
Query!
Approval date [1]
315557
0
12/10/2023
Query!
Ethics approval number [1]
315557
0
Query!
Summary
Brief summary
In Australia, gestational diabetes (GDM) affects around 10% of pregnancies with up to 30% of GDM pregnancies in a high-risk population. GDM carries a small but potentially important risk of adverse perinatal outcomes and a longer-term risk of metabolic abnormalities in mother and her offspring. Several factors such as patient’s age and family history and raised body mass index (BMI) are associated with future higher risk for GDM. Women who experienced repeated miscarriages were reported to have a higher prevalence of insulin resistance, which increases their risk for gestational diabetes. ;Although up to 20 % of pregnancies end up in an unintended termination of pregnancy there is a paucity of data examining impact of women reproductive history on their future risk of GDM. A recent metanalysis of 10 studies has revealed a 1.62-fold risk of gestational diabetes (95% CI: 1.32–1.98) compared to those never experiencing a miscarriage. In this metanalysis the majority of collected data were ascertained from patients’ questionnaires without effect measure being adjusted for GDM predisposing risk factors. We are planning to conduct a case control study which will compare the previous exposures to miscarriage/termination of pregnancies in women with and without diagnosis of GDM. We will be aiming to analyse data on 500 GDM women and these data will be matched with data on 500 women of similar age and BMI and ethnicity however without GDM. We have already collected data on 150 women with GDM with the miscarriage prevalence of 33%. The proposed study design will have power of 0.80 and of 0.05 to detect a difference of 70% in GDM incidence in women with and without history of pregnancy loss. Considering the large number of miscarriages, evaluating the link between previous pregnancy loss and hyperglycaemia may allow for an additional monitoring and earlier intervention in women at high risk for GDM.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
The data on 150 participants were previously collected in year 2022 as part of the study: "To determine an association between metformin use in gestational diabetes mellitus and vitamin B12 deficiency." Trial Id: ACTRN12620000397910. We intend to use relevant data from the trial "To determine an association between metformin use in gestational diabetes mellitus and vitamin B12 deficiency" in the present study.
Query!
Contacts
Principal investigator
Name
37542
0
Dr Malgorzata Brzozowska
Query!
Address
37542
0
Sutherland Hospital, Kareena Rd, Caringbah NSW 2229
Query!
Country
37542
0
Australia
Query!
Phone
37542
0
+61 2 9540 7111
Query!
Fax
37542
0
Query!
Email
37542
0
[email protected]
Query!
Contact person for public queries
Name
37543
0
Malgorzata Brzozowska
Query!
Address
37543
0
Sutherland Hospital, Kareena Rd, Caringbah NSW 2229
Query!
Country
37543
0
Australia
Query!
Phone
37543
0
+61 2 9540 7111
Query!
Fax
37543
0
Query!
Email
37543
0
[email protected]
Query!
Contact person for scientific queries
Name
37544
0
Malgorzata Brzozowska
Query!
Address
37544
0
Sutherland Hospital, Kareena Rd, Caringbah NSW 2229
Query!
Country
37544
0
Australia
Query!
Phone
37544
0
+61 2 9540 7111
Query!
Fax
37544
0
Query!
Email
37544
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
Query!
No/undecided IPD sharing reason/comment
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF